Prior to joining Meytav, Ido served as VP Business Development of ATI Technology Incubator, a Biomedix subsidiary, and was responsible for the evaluation and promotion of new investments in the incubator and other BD activities.

Before joining the Biomedix group, Ido served as Director of Professional Services for "FreeMind" Consulting Group, a consultancy firm, specialized in academic & commercial R&D plans, grant writing consultation and fund-raising activities for high-tech companies.

Ido holds MBA in Marketing and Finance from the Hebrew University in Jerusalem, and a BSc in Life Sciences and Management from Tel Aviv University, Israel.

Serves as Meytav CTO since July 2009.

Prior joining Meytav, served as Director, Product ID and Portfolio management in Teva Pharmaceuticals, specializing in Biosimilar and Hospital franchises (Autoimmune diseases, Oncology, Endocrinology and Wound healing). Responsible for project analysis, market opportunities evaluation and launch of the first Bio-similar product.

Orit was also the managing director of UBT Medical, a medical device start-up. The company developed ultrasonic, pneumatic and mechanical drug delivery devices in the urological field.

Orit also held several R&D and BD positions in Bio start-ups.

Meytav's Directors Board: